ATTR Amyloidosis During the COVID-19 Pandemic: Insights from a Global Medical Roundtable
The panel concluded that patients with ATTR amyloidosis who develop COVID-19 have a higher risk of mortality.
The panel concluded that patients with ATTR amyloidosis who develop COVID-19 have a higher risk of mortality.
Dr. Lehman will succeed David Atkinson, PhD, who is stepping down as Chair at the end of June.